ADC Therapeutics S.A.
USD1.07
+0.04 (+4.37%)
CEO
Ameet Mallik
IPO Date
2020-05-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NYSE
Country
CH
Open
$1.10
Prev. Close
$1.03
Day Low
$1.03
Day High
$1.12
52W Low
$0.78
52W High
$4.98
Market Cap
$0.14B
Volume
0.13M
| -1.2 |
| 31 Dec 2023 | FY | 96.4% | -345.1% | 161.9% | -67.7% | -0.84 | 4.97 | -0.6 |
| 31 Dec 2022 | FY | 98.4% | -74.9% | -197.8% | -32.0% | 1.63 | 5.31 | -1.9 |
| 31 Dec 2021 | FY | 95.9% | -678.2% | -138.5% | -37.2% | 0.84 | 7.10 | -6.7 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -73.4% | -47.9% | 0.34 | 11.14 | -8.5 |
| 31 Dec 2019 | FY | 100.0% | -4977.9% | -104.8% | -84.6% | 0.05 | 6.15 | -17.0 |
| 31 Dec 2018 | FY | -10258.4% | -10797.9% | -97.5% | -81.8% | 0.00 | 6.36 | -13.0 |
| 31 Dec 2017 | FY | -4643.8% | -4984.0% | -36.1% | -33.0% | 0.00 | 12.91 | -19.4 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 0.0% | 0.0% | 0.00 | 15.64 | 0.0 |
| -20.7 |
| 30 Sept 2025 | Q3 | 92.7% | -249.4% | 17.2% | -14.1% | -0.49 | 4.63 | -3.3 |
| 30 Jun 2025 | Q2 | 95.6% | -300.7% | 28.4% | -17.6% | -0.59 | 4.93 | -1.3 |
| 31 Mar 2025 | Q1 | 91.1% | -167.6% | 16.2% | -14.2% | -1.89 | 4.46 | -1.0 |
| 31 Dec 2024 | Q4 | 91.9% | -181.7% | 15.2% | -9.5% | -0.61 | 3.82 | -1.7 |
| 30 Sept 2024 | Q3 | 95.4% | -238.1% | 25.6% | -12.6% | -0.72 | 4.92 | -1.9 |
| 30 Jun 2024 | Q2 | 93.0% | -209.9% | 27.8% | -9.8% | -0.94 | 6.17 | -2.4 |
| 31 Mar 2024 | Q1 | 86.1% | -258.2% | 24.0% | -15.1% | -0.64 | 4.61 | -2.0 |
| 31 Dec 2023 | Q4 | -645.4% | -506.4% | 57.4% | -24.0% | -0.84 | 4.97 | -0.4 |